Skip to content

Author

Julia Chapman

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Preclinical evaluation of ixazomib for high-risk pediatric brain tumors

Using transcriptomic and proteomic approaches, ixazomib effectively triggers proteostatic stress responses and induces apoptosis across a histologic range of CNS malignancies and is effective against Myc-MB, ATRT and DMG tumors in vitro.

Elizabeth Janko, Faye Walker, Mathew Slade et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.